Cephalon Reinforces Important Prescribing And Dosing Information For FENTORA
Sep 20th 2007Drug InformationPain / Anesthetics
Cephalon, Inc. (Nasdaq: CEPH) communicated with healthcare professionals to clarify the appropriate patient selection, dosing and administration for FENTORA(R) (fentanyl buccal tablet) [C-II]. The company is sharing this information with the medical community to reinforce the appropriate prescribing and use of the medication. The letter, issued in collaboration with the U.S. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
